Market Overview:
The global antibodies market is expected to reach USD 128.8 billion by 2030, registering a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of chronic diseases, rising demand for monoclonal antibodies and antibody drug conjugates (ADCs), and technological advancements in the field of antibody-based therapeutics. Based on type, the global antibodies market is segmented into monoclonal antibodies (MAbs), polyclonal antibodies (PCAs), and antibody drug conjugates (ADCs). Monoclonal antibodies are further classified into humanized MAbs and chimeric MAbs. Polyclonal antibodies are produced from pooled sera obtained from multiple animals immunized with a specific antigen. Antibody drug conjugates are composed of an antigen-binding domain derived from an antibody linked to a cytotoxic agent such as a chemotherapeutic agent or radioisotope. On the basis of application, the global antibiotics market is segmented into hospitals, long-term care facilities, research institutes, and others including clinics/private practice laboratories and veterinary clinics/animal hospitals. Hospitals account for the largest share of this market owing to rising incidence rates of chronic diseases that require hospitalization for treatment such as cancer and autoimmune disorders . In addition, growing demand for targeted therapies has led hospitals to increasingly adopt monoclonal antibody therapies .
Product Definition:
Antibodies are proteins that our immune system uses to identify and neutralize foreign objects such as bacteria and viruses. They are produced when our body is exposed to antigens, which are the molecules on the surface of these foreign objects. Antibodies can be used in diagnostic tests to identify infections, and they can also be used therapeutically to treat diseases caused by pathogens.
Monoclonal antibodies:
Monoclonal antibodies are antibody produced by the body's immune system specifically targeting and binding to a specific harmful invader. The immune system creates several different types of antibodies in response to foreign objects such as bacteria, viruses or cancer cells. These monoclonal antibodies (mAbs) can either be used on their own or attached with therapeutic proteins for treating various diseases such as rheumatoid arthritis, lupus, etc.
Polyclonal antibodies:
Polyclonal antibodies are made by B cells and are used to identify, measure, or modify the immune response. They play an important role in autoimmune diseases such as rheumatoid arthritis and lupus. In addition, they have applications in oncology (cancer), immunology (inflammation), neurology (neurological disorders) & ophthalmology among others.
Application Insights:
The research institutes segment dominated the global market in 2017. This is attributed to factors such as increasing government funding for R&D and growing emphasis on antibody-based drugs for the treatment of various diseases. For instance, according to data published by the European Society for Clinical Investigation, an estimated USD 28 billion worth of antibody-based drugs were approved by U.S FDA between 2014 and 2016.
Moreover, a rise in prevalence of chronic diseases such as cancer and autoimmune disorders has created a significant need for innovative drug development that utilizes human immune cells as therapeutic platforms. This factor is anticipated to drive product demand over the forecast period since it can be used both in vitro and in vivo without any known toxicity issues or allergic reactions towards animal models tested so far (injurious sign reaction).
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of biotechnology and pharmaceutical companies, advanced healthcare infrastructure, high adoption rate for new technologies and rising prevalence of chronic diseases are some factors responsible for its largest share. Moreover, increasing government funding to support R&D activities is also expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to untapped opportunities in this region coupled with rapidly improving healthcare infrastructure and growing investments by governments & private players for generating revenue from innovative therapies & diagnostic procedures. Rising awareness regarding cancer immunotherapy treatment options along with constantly improving healthcare facilities are some factors that can be attributed for future growth prospects in Asia Pacific region as well as other regions across the world (for instance Latin America).
Growth Factors:
- Increasing prevalence of autoimmune diseases and cancer is expected to drive the demand for antibodies over the forecast period.
- Growing investments in R&D by biotechnology and pharmaceutical companies is anticipated to propel the growth of antibodies market.
- Rising number of clinical trials for antibody-based therapies is projected to boost the growth of this market in near future.
- Technological advancements in antibody production are likely to provide new opportunities for this market during forecast period .
Scope Of The Report
Report Attributes
Report Details
Report Title
Antibodies Market Research Report
By Type
Monoclonal antibodies, Polyclonal antibodies, Antibody drug conjugates
By Application
Hospitals, Long-term care facilities, Research institutes
By Companies
Novartis, F. Hoffmann-La Roche, Johnson & Johnson Services, Amgen, Bristol-Myers Squibb, AbbVie, Eli Lilly, Novartis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
141
Number of Tables & Figures
99
Customization Available
Yes, the report can be customized as per your need.
Global Antibodies Market Report Segments:
The global Antibodies market is segmented on the basis of:
Types
Monoclonal antibodies, Polyclonal antibodies, Antibody drug conjugates
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Long-term care facilities, Research institutes
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis
- F. Hoffmann-La Roche
- Johnson & Johnson Services
- Amgen
- Bristol-Myers Squibb
- AbbVie
- Eli Lilly
- Novartis
Highlights of The Antibodies Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Monoclonal antibodies
- Polyclonal antibodies
- Antibody drug conjugates
- By Application:
- Hospitals
- Long-term care facilities
- Research institutes
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Antibodies Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Antibodies are proteins that help the body fight against infection. When a person is infected with a virus, the body produces antibodies to fight off the infection. Antibodies can be found in blood, saliva, and other fluids.
Some of the major companies in the antibodies market are Novartis, F. Hoffmann-La Roche, Johnson & Johnson Services, Amgen, Bristol-Myers Squibb, AbbVie, Eli Lilly, Novartis.
The antibodies market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Antibodies Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Antibodies Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Antibodies Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Antibodies Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Antibodies Market Size & Forecast, 2020-2028
4.5.1 Antibodies Market Size and Y-o-Y Growth
4.5.2 Antibodies Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Monoclonal antibodies
5.2.2 Polyclonal antibodies
5.2.3 Antibody drug conjugates
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Long-term care facilities
6.2.3 Research institutes
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Antibodies Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Antibodies Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Monoclonal antibodies
9.6.2 Polyclonal antibodies
9.6.3 Antibody drug conjugates
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Long-term care facilities
9.10.3 Research institutes
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Monoclonal antibodies
10.6.2 Polyclonal antibodies
10.6.3 Antibody drug conjugates
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Long-term care facilities
10.10.3 Research institutes
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Monoclonal antibodies
11.6.2 Polyclonal antibodies
11.6.3 Antibody drug conjugates
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Long-term care facilities
11.10.3 Research institutes
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Monoclonal antibodies
12.6.2 Polyclonal antibodies
12.6.3 Antibody drug conjugates
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Long-term care facilities
12.10.3 Research institutes
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Monoclonal antibodies
13.6.2 Polyclonal antibodies
13.6.3 Antibody drug conjugates
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Long-term care facilities
13.10.3 Research institutes
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Antibodies Market: Competitive Dashboard
14.2 Global Antibodies Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis
14.3.2 F. Hoffmann-La Roche
14.3.3 Johnson & Johnson Services
14.3.4 Amgen
14.3.5 Bristol-Myers Squibb
14.3.6 AbbVie
14.3.7 Eli Lilly
14.3.8 Novartis
